Patent · US Active

Azaindazoles

US9073924B2 · kind B2 · utility

3Cited by

1References

2Claims

0Family size

Assignee

GlaxoSmithKline LLC · US

Inventors

Joelle Lorraine Burgess · Collegeville, US
Neil W. Johnson · Collegeville, US
Steven David Knight · West Chester, US
Louis Lafrance · Collegeville, US
William Henry Miller · Collegeville, US
Kenneth A. Newlander · West Chester, US
Stuart Paul Romeril · Collegeville, US
Meagan B. Rouse · Collegeville, US
Dominic Suarez · Collegeville, US
Xinrong Tian · Collegeville, US
Sharad Kumar Verma · New Haven, US

Key dates

Filing date	Sep 12, 2012
Grant date	Jul 7, 2015
Priority date	—
Expiry date	Sep 12, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Herein are disclosed azaindazoles of formula (I)where the various groups are defined herein, and which are useful for treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.